Henrik J. Ditzel

IFI16-dependent STING signaling is a crucial regulator of anti-HER2 immune response in HER2+ breast cancer

L.S. Ong, Wee Chyan Lee, Shijun Ma et al. · Proceedings of the National Academy of Sciences · 2022 · 567 citations · Full text

Life Sciences, Immunology, Oncology +17

CYP2D6 Genotype and Tamoxifen Response in Postmenopausal Women with Endocrine-Responsive Breast Cancer: The Breast International Group 1-98 Trial

Meredith M. Regan, Brian Leyland‐Jones, Mark Bouzyk et al. · JNCI Journal of the National Cancer Institute · 2012 · 338 citations · Full text

Medicine, Oncology, Pharmacology +16

Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non–Small Cell Lung Cancer

Tom Dønnem, Sigurd M. Hald, Erna‐Elise Paulsen et al. · Clinical Cancer Research · 2015 · 329 citations

Life Sciences, Immunology, Oncology +17

Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC

Imane Chaib, Niki Karachaliou, Sara Pilotto et al. · JNCI Journal of the National Cancer Institute · 2017 · 216 citations · Full text

Medicine, Oncology, Pharmacology +17

Autoantibodies to GPI in rheumatoid arthritis: linkage between an animal model and human disease

Monica Schaller, Dennis R. Burton, Henrik J. Ditzel · Nature Immunology · 2001 · 208 citations

Life Sciences, Immunology, Molecular Biology +16